Literature DB >> 7508124

CP-96,345, a substance P antagonist, inhibits rat intestinal responses to Clostridium difficile toxin A but not cholera toxin.

C Pothoulakis1, I Castagliuolo, J T LaMont, A Jaffer, J C O'Keane, R M Snider, S E Leeman.   

Abstract

Toxin A from Clostridium difficile mediates acute inflammatory enterocolitis in experimental animals, while cholera toxin causes noninflammatory secretory diarrhea. The purpose of this study was to investigate whether an antagonist to the peptide substance P, a constituent of primary sensory neurons known to participate in inflammatory responses, would inhibit toxin A-mediated enteritis in the rat ileum. Pretreatment of rats with CP-96,345 (2.5 mg per kg of body weight), a substance P antagonist, dramatically inhibited fluid secretion (P < 0.01) and mannitol permeability (P < 0.01) in ileal loops exposed to toxin A. The protective effects, which were dose dependent, caused a significant reduction of inflammation in the lamina propria, reduction of the necrosis of intestinal epithelial cells, and complete inhibition of toxin A-mediated release of rat mast cell protease II, a specific product of rat mucosal mast cells. An inactive enantiomer of the substance P antagonist, CP-96,344, had no effect. In contrast, pretreatment with CP-96,345 had no inhibitory effect on the intestinal effects caused by administration of cholera toxin into the ileal loops. From these data, we conclude that the peptide substance P is involved in the secretory and inflammatory effects of toxin A but not of cholera toxin.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7508124      PMCID: PMC521430          DOI: 10.1073/pnas.91.3.947

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

1.  Modulation of the mRNAs encoding substance P and its receptor in rat macrophages by LPS.

Authors:  K L Bost; S A Breeding; D W Pascual
Journal:  Reg Immunol       Date:  1992 Mar-Apr

2.  Molecular characterization of the Clostridium difficile toxin A gene.

Authors:  C H Dove; S Z Wang; S B Price; C J Phelps; D M Lyerly; T D Wilkins; J L Johnson
Journal:  Infect Immun       Date:  1990-02       Impact factor: 3.441

3.  Clostridium difficile cytotoxin inhibits protein synthesis in fibroblasts and intestinal mucosa.

Authors:  C Pothoulakis; G Triadafilopoulos; M Clark; C Franzblau; J T LaMont
Journal:  Gastroenterology       Date:  1986-11       Impact factor: 22.682

Review 4.  The neuropharmacology of capsaicin: review of some recent observations.

Authors:  S H Buck; T F Burks
Journal:  Pharmacol Rev       Date:  1986-09       Impact factor: 25.468

5.  Effect of toxin A and B of Clostridium difficile on rabbit ileum and colon.

Authors:  T J Mitchell; J M Ketley; S C Haslam; J Stephen; D W Burdon; D C Candy; R Daniel
Journal:  Gut       Date:  1986-01       Impact factor: 23.059

6.  Mast cell heterogeneity: effects of neuroenteric peptides on histamine release.

Authors:  F Shanahan; J A Denburg; J Fox; J Bienenstock; D Befus
Journal:  J Immunol       Date:  1985-08       Impact factor: 5.422

7.  Effect of CP-96,345, a nonpeptide substance P receptor antagonist, on salivation in rats.

Authors:  R M Snider; K P Longo; S E Drozda; J A Lowe; S E Leeman
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-15       Impact factor: 11.205

8.  Localization of targets for anti-ulcer drugs in cells of the immune system.

Authors:  E Mezey; M Palkovits
Journal:  Science       Date:  1992-12-04       Impact factor: 47.728

9.  Increased levels of substance P in the myenteric plexus of Trichinella-infected rats.

Authors:  M G Swain; A Agro; P Blennerhassett; A Stanisz; S M Collins
Journal:  Gastroenterology       Date:  1992-06       Impact factor: 22.682

10.  Diminished Clostridium difficile toxin A sensitivity in newborn rabbit ileum is associated with decreased toxin A receptor.

Authors:  R Eglow; C Pothoulakis; S Itzkowitz; E J Israel; C J O'Keane; D Gong; N Gao; Y L Xu; W A Walker; J T LaMont
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

View more
  85 in total

1.  p38 MAP kinase activation by Clostridium difficile toxin A mediates monocyte necrosis, IL-8 production, and enteritis.

Authors:  M Warny; A C Keates; S Keates; I Castagliuolo; J K Zacks; S Aboudola; A Qamar; C Pothoulakis; J T LaMont; C P Kelly
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

2.  The involvement of macrophage-derived tumour necrosis factor and lipoxygenase products on the neutrophil recruitment induced by Clostridium difficile toxin B.

Authors:  M H Souza; A A Melo-Filho; M F Rocha; D M Lyerly; F Q Cunha; A A Lima; R A Ribeiro
Journal:  Immunology       Date:  1997-06       Impact factor: 7.397

Review 3.  Irritable bowel syndrome: methods, mechanisms, and pathophysiology. Neural and neuro-immune mechanisms of visceral hypersensitivity in irritable bowel syndrome.

Authors:  Bin Feng; Jun Ho La; Erica S Schwartz; G F Gebhart
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-03-08       Impact factor: 4.052

4.  Experimental colitis triggers the release of substance P and calcitonin gene-related peptide in the urinary bladder via TRPV1 signaling pathways.

Authors:  Xiao-Qing Pan; Jessica A Gonzalez; Shaohua Chang; Samuel Chacko; Alan J Wein; Anna P Malykhina
Journal:  Exp Neurol       Date:  2010-05-23       Impact factor: 5.330

5.  Rabbit sucrase-isomaltase contains a functional intestinal receptor for Clostridium difficile toxin A.

Authors:  C Pothoulakis; R J Gilbert; C Cladaras; I Castagliuolo; G Semenza; Y Hitti; J S Montcrief; J Linevsky; C P Kelly; S Nikulasson; H P Desai; T D Wilkins; J T LaMont
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

6.  Protease-activated receptor 2, dipeptidyl peptidase I, and proteases mediate Clostridium difficile toxin A enteritis.

Authors:  Graeme S Cottrell; Silvia Amadesi; Stella Pikios; Eric Camerer; J Adam Willardsen; Brett R Murphy; George H Caughey; Paul J Wolters; Shaun R Coughlin; Anders Peterson; Wolfgang Knecht; Charalabos Pothoulakis; Nigel W Bunnett; Eileen F Grady
Journal:  Gastroenterology       Date:  2007-04-13       Impact factor: 22.682

7.  Neutral endopeptidase (EC 3.4.24.11) downregulates the onset of intestinal inflammation in the nematode infected mouse.

Authors:  G Barbara; R De Giorgio; V Stanghellini; R Corinaldesi; C Cremon; N Gerard; C Gerard; E F Grady; N W Bunnett; P A Blennerhassett; S M Collins
Journal:  Gut       Date:  2003-10       Impact factor: 23.059

8.  Substance P stimulates cyclooxygenase-2 and prostaglandin E2 expression through JAK-STAT activation in human colonic epithelial cells.

Authors:  Hon-Wai Koon; Dezheng Zhao; Yanai Zhan; Sang Hoon Rhee; Mary P Moyer; Charalabos Pothoulakis
Journal:  J Immunol       Date:  2006-04-15       Impact factor: 5.422

9.  Substance P-stimulated interleukin-8 expression in human colonic epithelial cells involves Rho family small GTPases.

Authors:  Dezheng Zhao; Sabina Kuhnt-Moore; Huiyan Zeng; Amy Pan; Jack S Wu; Simos Simeonidis; Mary P Moyer; Charalabos Pothoulakis
Journal:  Biochem J       Date:  2002-12-01       Impact factor: 3.857

10.  Rifalazil treats and prevents relapse of clostridium difficile-associated diarrhea in hamsters.

Authors:  Pauline M Anton; Michael O'Brien; Efi Kokkotou; Barry Eisenstein; Arthur Michaelis; David Rothstein; Sophia Paraschos; Ciáran P Kelly; Charalabos Pothoulakis
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.